Nitrazepam Richter (Nitrazepam)

Nitrazepam binds to the benzodiazepine site on the GABA‑A receptor complex, acting as a positive allosteric modulator. This increases the frequency of chloride channel opening when GABA binds, leading to greater neuronal inhibition and producing sedative, anxiolytic, anticonvulsant, and muscle‑relaxant effects.

The appropriate dose of Nitrazepam Richter is determined by the prescribing healthcare professional based on the individual’s medical condition, age, response to therapy, and other factors. Patients should follow the prescriber’s instructions and never adjust the dose on their own.

Safety data for nitrazepam in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives with their healthcare provider.

To order Nitrazepam Richter, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nitrazepam shares the core mechanism of GABA‑A modulation with other benzodiazepines but has a relatively long half‑life, which can provide sustained therapeutic effect for insomnia and anxiety. Compared with shorter‑acting agents, it may have a higher risk of next‑day sedation but offers less frequent dosing.

Nitrazepam Richter should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and heat sources to maintain its stability and potency throughout its shelf life.

Nitrazepam Richter is taken orally, usually as a tablet, with or without food as directed by the prescriber. Swallow the tablet whole with a glass of water and follow the dosing schedule provided by the healthcare professional.

Serious risks include respiratory depression, severe hypotension, paradoxical reactions such as agitation or aggression, suicidal thoughts or behavior, severe skin reactions, and the potential for dependence, tolerance and withdrawal after prolonged use.

Nitrazepam Richter should be avoided in individuals with known hypersensitivity to nitrazepam or other benzodiazepines, those with severe respiratory insufficiency, acute narrow‑angle glaucoma, or severe hepatic impairment. Caution is also advised for patients with a history of substance abuse or severe depression.